An experimental treatment failed in mice, and researchers did the right thing: They published about it

Blocking the mutant protein with an antibody didn’t stop the strange, abnormal bone growths in mice. But the knowledge gained could steer scientists toward more promising approaches, report researchers from UConn and Alexion Pharmaceuticals in the 15 June issue of the Journal of Clinical Investigation.

This post was originally published on this site

Lawyers Lookup - LawyersLookup.ca